These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 17206800)

  • 21. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
    Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery.
    Chuang EY; Lin KJ; Su FY; Chen HL; Maiti B; Ho YC; Yen TC; Panda N; Sung HW
    J Control Release; 2013 Aug; 169(3):296-305. PubMed ID: 23195534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of size tunable amphiphilic poly(amino acid) nanoparticles.
    Kim H; Akagi T; Akashi M
    Macromol Biosci; 2009 Sep; 9(9):842-8. PubMed ID: 19422015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats.
    Chuang EY; Lin KJ; Su FY; Mi FL; Maiti B; Chen CT; Wey SP; Yen TC; Juang JH; Sung HW
    J Control Release; 2013 Dec; 172(2):513-22. PubMed ID: 23702234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery.
    Lee PW; Peng SF; Su CJ; Mi FL; Chen HL; Wei MC; Lin HJ; Sung HW
    Biomaterials; 2008 Feb; 29(6):742-51. PubMed ID: 18001831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
    Yeh MK; Cheng KM; Hu CS; Huang YC; Young JJ
    Acta Biomater; 2011 Oct; 7(10):3804-12. PubMed ID: 21742066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
    Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
    Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization.
    Qian F; Cui F; Ding J; Tang C; Yin C
    Biomacromolecules; 2006 Oct; 7(10):2722-7. PubMed ID: 17025345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
    Lin CC; Lin CW
    Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Free amino groups on the surface of chitosan nanoparticles and its characteristics].
    Lin AH; Liu YM; Ping QN
    Yao Xue Xue Bao; 2007 Mar; 42(3):323-8. PubMed ID: 17520835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats.
    Ma Z; Lim TM; Lim LY
    Int J Pharm; 2005 Apr; 293(1-2):271-80. PubMed ID: 15778065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Saadat P; Rafiee-Tehrani M; Junginger HE
    Int J Pharm; 2008 May; 355(1-2):299-306. PubMed ID: 18206322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
    J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The t-PA-encapsulated PLGA nanoparticles shelled with CS or CS-GRGD alter both permeation through and dissolving patterns of blood clots compared with t-PA solution: an in vitro thrombolysis study.
    Wang SS; Chou NK; Chung TW
    J Biomed Mater Res A; 2009 Dec; 91(3):753-61. PubMed ID: 19051299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monodisperse chitosan nanoparticles for mucosal drug delivery.
    Zhang H; Oh M; Allen C; Kumacheva E
    Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral bioavailability of insulin contained in polysaccharide nanoparticles.
    Sarmento B; Ribeiro A; Veiga F; Ferreira D; Neufeld R
    Biomacromolecules; 2007 Oct; 8(10):3054-60. PubMed ID: 17877397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-dependent disruption of erythrocyte membrane by amphiphilic poly(amino acid) nanoparticles.
    Akagi T; Kim H; Akashi M
    J Biomater Sci Polym Ed; 2010; 21(3):315-28. PubMed ID: 20178688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.